Well take comfort that we are no longer wondering when the stock is going to go under a nickel:)
We had a HUGE run earlier this year.. and at .22-.23 we are STILL holding hundreds of percent gains..
I suspect the next huge run will rip through the highs of the first run..
and who knows.. perhaps we will just keep going for a while.. and then of course at some point the "traders" will hop off the rocket and we will settle in to some higher range.
I am not trying to defend the stock price.. because I think the stock is ridiculously low as well:).. but I remind myself to look at the market cap.. and to take into consideration some of the dilution (which has been necessary).. so .22 today.. would have been somewhat higher a year, 2 years ago..
Still, the more data we get (and NOW we know we will almost certainly get data from a Covid trial).. the more dangerous it is for manipulators to be on the wrong side of the trade..
imo they can get away with it as long as volume stays away from the stock.. and it is kind of self reinforcing (the manipulation).. because some traders/investors might stay away if they think the stock is being manipulated..
again, this can only work before the crowd comes:).. and imo the crowd arrives once it is even clearer where the Covid trial is headed..
yes, some stocks are going to run just based on anticipation of such a trial (on low volume).. and that low volume can create higher volume as the pps increases..
unfortunately we are not being given that luxury and must wait for more definitive data.. OR this could change in an instant.. with the right article, trading group, whale investor.. that would jump start the volume.
Personally, I have prepared myself (or perhaps investing in IPIX has prepared me.. lol) Like most long term longs.. not much surprises me anymore.
But Science (third party validation) is hard to fake. And that is what I have resigned myself to invest in when it comes to this company.
Fortunately, the signs point to the mechanisms being in place to let the Science reveal itself (Covid trial will happen and there will be an audience for good/great data)..
Hard to bury this one:)
And thanks for reading (if you got this far:)